FACTFLOW

Monday, 30 March 2026 · Global Edition · Updated 23:25 CST

Pacira Biosciences slips as 2026 revenue guidance, Q4 2025 results disappoint

X3 Holdings approves 30-for-1 share consolidation

Wendel reports FY results

GoodRx expects Pharma Direct revenue growth of at least 30% in 2026 amid shift to pharma manufacturer solutions

Adtran outlines $275M-$295M Q1 2026 revenue target as fiber and optical momentum continues

Delcath targets at least $100M revenue in 2026 while expanding to 40 treatment centers

Hellenic Telecommunications reports Q4 results

Drax Group plc reports FY results

Novavax outlines $230M–$270M 2026 revenue target with new Pfizer partnership and cost reduction strategy

Ecopetrol FY 2025 Earnings Preview

Delek Logistics Partners Q4 2025 Earnings Preview

Cheniere Energy targets $7.25B adjusted EBITDA and 51–53M tonnes LNG production in 2026 while expanding capital returns

Global Partners Q4 Earnings Preview

Endeavour Silver Q4 2025 Earnings Preview

Nvidia leads chip stocks lower, investors worry about AI buildout plans

Prev 1 … 126 127 128 129 130 131 132 … 230 Next